Skip to content
Screener

GoodRx Holdings, Inc. GDRX Subscription revenue — Revenue

Other product segments

Pharma manufacturer solutions revenue
$151.38M
Prescription transactions revenue
$106.39M-25.6%
Pharma Direct revenue
$61.63M+76.2%
Other revenue
$3.88M-15.0%

Similar metrics at other companies

Clarivate logo
CLVTSubscription revenues — Revenue
$403.3M-0.6%
WW International, Inc. logo
WWBehavioral Subscription Revenues — Revenue
$121.49M-17.3%
WW International, Inc. logo
WWClinical Subscription Revenues — Revenue
$39.91M+38.3%
WW International, Inc. logo
WWSubscription Revenues Net — Revenue
$161.39M-8.2%
Samsara logo
IOTSubscription revenue — Revenue
$470.98M+31.0%
Navan, Inc. logo
NAVNSubscription revenue — Revenue
$18.1M+26.4%

Other financials

Income statement

See full
Revenue$200.4M-1.3%
Gross profit$179.4M-5.4%
Operating income$23.6M-11.9%
Net income$8.5M-33.5%
EPS (diluted)$0.02-50.0%

Balance sheet

See full
Cash & equivalents$296.1M+5.3%
Total debt$539.0M-1.6%
Total equity$647.6M+0.7%
Total assets$2.3B+77.7%

Cash flow

See full
Operating cash flow$80.8M+63.0%
CapEx$362.0K-7.2%
Free cash flow$80.5M+63.6%

Valuation

See full
Market cap$1.27B+3.8%
Enterprise value$1.51B+1.6%
P/E78.1×+42.8×
P/S1.6×+0.1×

Profitability

See full
Gross margin90.8%-2.8pp
Operating margin9.5%-1.6pp
Net margin2.1%-2.3pp
FCF margin25.1%+1.4pp

Returns & leverage

See full
Return on equity2.5%-2.8pp
Debt / equity0.8×0.0×
Current ratio1.4×-2.8×

Where this comes from

Reported directly by GoodRx Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: GoodRx Holdings, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:09 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001809519-26-000152
(in thousands)Three Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Prescription transactions revenue$106,390$143,064$220,082$291,987
Subscription revenue28,51420,46352,90741,480
Pharma Direct revenue61,62834,981113,85863,629
Other revenue3,8794,5627,5708,944
Total revenue$200,411$203,070$394,417$406,040

Item 1. Financial Statements

FAQ

What is GoodRx Holdings, Inc.'s subscription revenue — revenue?
GoodRx Holdings, Inc. (GDRX) reported subscription revenue — revenue of $28.51M in Q2 2026.
How has GoodRx Holdings, Inc.'s subscription revenue — revenue changed year-over-year?
GoodRx Holdings, Inc.'s subscription revenue — revenue increased by 39.3% year-over-year, from $20.46M to $28.51M.
What is the long-term trend for GoodRx Holdings, Inc.'s subscription revenue — revenue?
Over 4 years (2021 to 2025), GoodRx Holdings, Inc.'s subscription revenue — revenue has grown at a 8.7% compound annual growth rate (CAGR), from $59.93M to $83.73M.
What does subscription revenue — revenue mean?
This metric represents the total revenue generated from recurring subscription-based services offered to consumers, distinct from transaction-based or advertising revenue streams. It reflects the company's ability to monetize its platform through membership fees that provide users with enhanced access to discounted healthcare services and prescription pricing. Tracking this revenue stream is essential for evaluating the stability and predictability of the company's recurring business model.

Ask your AI about GoodRx Holdings, Inc.'s subscription revenue — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude